Professor Michael Friedlander is conjoint Professor of Medicine at The University of New South Wales and Director of Medical Oncology at the Prince of Wales Cancer Centre in Sydney. He has appointments at The Royal Hospital for Women and The Prince of Wales Private Hospital and has a busy private practice at Suite 20. For patients requiring systemic chemotherapy, they may be treated in the oncology day centres at all 3 hospitals.

Major Clinical Interests include Gynaecological Cancers, Breast Cancer, Soft Tissue Sarcomas and Germ Cell Tumours.

He has been very active at both a National and International level in the field of Gynaecological Oncology. He was President of the International Society of Gynaecological Oncology (IGCS) from 2004-2006. He is a senior editor of the International Journal of Gynaecological Oncology. He was the founding Chairman of the ANZ Gynaecology Oncology Group (ANZGOG) and has held this position from 2000-2008 and remains on the ANZGOG executive and is currently the Research Director of ANZGOG.He is the Principle Investigator for ANZGOG in the US GOG as well as an ANZGOG representative to the Gynaecological Cancer Inter-Group (GCIG).